Literature DB >> 10071481

Age-related decrease in accessory cell function of human alveolar macrophages.

G Zissel1, M Schlaak, J Müller-Quernheim.   

Abstract

BACKGROUND: Suboptimal function of an aged immune system may significantly contribute to morbidity and mortality in the elderly. In contrast to lymphocytes, only little is known about changes of cells from the monocyte/macrophage lineage. Especially the changes of their accessory function, which are necessary for optimal T cell stimulation are controversially discussed.
METHODS: We measured the accessory function of monocytes (PBM) and alveolar macrophages (AM) and correlated their accessory function with the age of the patients.
RESULTS: We found a significant decrease in accessory function of AM with the age (rs = -0.5, P < 0.006) but not of PBM (rs = -0.4, P > 0.1). Additionally, we found a significant decrease in the percentage of AM (rs = 0.3, P < 0.005) and an increase in the percentage of lymphocytes (rs = 0.3, P < 0.02) in the bronchoalveolar lavage. No correlations could be found with other lavage parameters or with unstimulated in vitro TNF-alpha, TGF-beta, and IL-6 release of bronchoalveolar lavage cells; however, in stimulated BAL-cell cultures we found a weak but significant correlation between TNF-alpha release and the age (rs = -0.3, P < 0.02).
CONCLUSIONS: Impairment of accessory cell function of alveolar macrophages may contribute to an increased risk of pulmonary infection of elderly persons.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10071481

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  17 in total

1.  Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Authors:  Adrian J Reber; Tatiana Chirkova; Jin Hyang Kim; Weiping Cao; Renata Biber; David K Shay; Suryaprakash Sambhara
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

Review 2.  Cell Therapy Strategies to Combat Immunosenescence.

Authors:  Elizabeth C Stahl; Bryan N Brown
Journal:  Organogenesis       Date:  2015-11-20       Impact factor: 2.500

Review 3.  Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes.

Authors:  Robert D Stout; Jill Suttles
Journal:  Immunol Rev       Date:  2005-06       Impact factor: 12.988

Review 4.  Effects of age-related shifts in cellular function and local microenvironment upon the innate immune response to implants.

Authors:  Bryan N Brown; Martin J Haschak; Samuel T Lopresti; Elizabeth C Stahl
Journal:  Semin Immunol       Date:  2017-05-20       Impact factor: 11.130

Review 5.  Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.

Authors:  Judy Chen; William J Kelley; Daniel R Goldstein
Journal:  J Immunol       Date:  2020-06-03       Impact factor: 5.422

6.  IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice.

Authors:  C Jackaman; D E Dye; D J Nelson
Journal:  Age (Dordr)       Date:  2014-04-19

7.  Microglia in the aging brain: relevance to neurodegeneration.

Authors:  Xiao-Guang Luo; Jian-Qing Ding; Sheng-Di Chen
Journal:  Mol Neurodegener       Date:  2010-03-24       Impact factor: 14.195

8.  Human neutrophil peptide-1 decreases during ageing in selected Mexican population.

Authors:  Bruno Rivas-Santiago; Julio E Castañeda-Delgado; Jeny de Haro-Acosta; Flor Torres-Juarez; Isabel Frausto-Lujan; Paulina Marin-Luevano; Roberto González-Amaro; Jose A Enciso-Moreno
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

9.  Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis.

Authors:  Wu He; Arturo Casadevall; Sunhee C Lee; David L Goldman
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

Review 10.  Immunological outcomes of exercise in older adults.

Authors:  David S Senchina; Marian L Kohut
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.